Dialog Pharma/Biotech News Issue 6
December 2006
A community-of-interest newsletter for Dialog customers

In This Issue

Adis Clinical Trials Insight Reloaded with New Fields

IMS R&D Focus: Added Content, Improved Functionality

Publisher Records in MEDLINE on DataStar

Elsevier Science Introduces New Bibliographic Data Elements

Comprehensive Drug Monitoring Using Chemical Structures in the Pipeline Databases

Search Techniques


Call for Contributors

Search Techniques

Limits in Adis Clinical Trials Insight

Limit your search to new document types in Dialog File 173:

/ONGOING — Ongoing trial
/SUPPORT — Supporting evidence
— Best evidence
/CIT — Citation only

Each type of record contains different data with Best Evidence records being the most complete.

If searching DataStarWeb (ACTI) Easy Search, limit by using the "Restrict to" drop-down menu to select a specific document type; in Advanced Search check the box next to the document type(s) to retrieve.


Changes to Therapeutic Coding of IMS Files

Some changes have been made to the therapeutic coding used in IMS R&D Focus (File 445,955/IPUR) and IMS Patent Focus (File 447,947/IPIP). If you use therapeutic codes in your searching or for Alerts, check your Alerts or search strategies to see if changes are necessary.

FSTA Expands Veterinary Coverage

Food Science and Technology Abstracts® (File 51/FSTA) has expanded its coverage to include a broader range of material from veterinary journals, such as Journal of Veterinary Public Health and Veterinary Research.

Focus on the news you want... Dialog e-Newsletters


MEDLINE Suspends Updating for Annual

MEDLINE (File 154, 155/MEDL, MEZZ) has ceased updating as it does every year while the National Library of Medicine (NLM) re-indexes the file with new and changed Medical Subject Headings (MeSH). The file is expected to start updating again towards the end of 2006 or beginning of 2007. The full reload will take place in early 2007.

Dear Colleague

Bonnie SnowRecent Dialog Pharmaceutical Forums held in numerous locations presented sessions on how to get the most from the pharmaceutical databases on Dialog and DataStar. Attendees were very interested in pharmacovigilance and chemical structure searching in the Dialog pipeline databases, two of the topics covered in the Forums. More Pharmaceutical Forums are planned for 2007. Dates and locations will be announced in an upcoming issue of Pharma/Biotech News.

In this issue we highlight some of the changes in the Adis and IMS drug pipeline files. See how new fields added to the databases will allow you to structure your searches and Alerts more specifically and gain the latest information about ongoing clinical trials.

Bonnie Snow, Director
Pharmaceutical Markets

Adis Clinical Trials Insight Reloaded with New Fields

BeekersAdis Clinical Trails Insight (File 173, 373/ACTI) has been reloaded with new fields to let you pinpoint exactly the information you need and track the latest developments in ongoing clinical trials. New fields in the file include: Drug Name, References, ATC WHO Codes, EphMRA codes, creation date, study identifiers, Adis R&D Insight (File 107/ADRD) links, meeting name, study name, patient minimum and maximum age/units, planned number of patients, Study status, Latest update date.

Comprehensive Information about Ongoing Trials
Updated weekly, Adis Clinical Trials Insight is the only place to retrieve data about ongoing trials, as well as presented and published trial data in a single searchable database. Set up Alerts to help identify and assess the growing universe of clinical trial studies for new drugs and therapies. File 173 also contains full assessments of important trials from 1990 to the present and includes coverage of more than 40,000 published and ongoing trials per year.

IMS R&D Focus: Added Content, Improved Functionality

BeekersIMS R&D Focus (IPUR) on DataStar has been reloaded resulting in more content and improved functionality. Additional data enable you to identify important concepts in drug research such as:

  • Whether a drug is in active development
  • Whether the document has undergone a major change
  • Whether the major change is a development phase change
  • Route of Administration

New fields enable you to set up your Alert strategies to focus specifically on areas like document and development phase changes or route of administration.

Publisher Records in MEDLINE® on DataStar

Group MeetingPublisher records are now available in MEDLINE (MEDL, MEZZ, MEIP) on DataStar. There are several differences between these records and those in MEDLINE:

  • Foreign language articles often do not have an English-language title
  • Some records are out of MEDLINE’s usual content scope
  • Journal titles are only available in abbreviated form

Publisher records are handled in the same way as other “In Process” records and will be overwritten when they appear in MEDLINE later. You can retrieve Publisher records on DataStar with PUBLISHER=YES or PUBLISHER.AN. and identify them by the presence of the word “Publisher” in the Accession Number field.

Elsevier Science Introduces New Bibliographic Data Elements

BeekersElsevier has introduced some new publication types and associated features in EMBASE (File 72,73/EMED,EMZZ), Elsevier BioBase (File 71/ELBI) and EMCare (File 45/EMCA). The new features include:

  • Two new publication types: "Trade Journal" and "Proceeding"’
  • Titles of journal issues that have their own distinct title
  • Names of editors of specific issues
  • ISBNs of journals that are book series; both 10- and 13-digit ISBNs are provided where available

Comprehensive Drug Monitoring Using Chemical Structures in the Pipeline Databases

Beeker close upFor a comprehensive understanding of the current drug research environment, it is vital to consult multiple databases. A study by Diane Q. Webb and John A. Willmore of BizInt Solutions Inc. shows that searching only one pipeline database will generally retrieve only about 40 percent of the unique compounds in the pipelines of all drug companies.

Read the article by Bob Stewart, entitled "Comprehensive Drug Monitoring Through Multi-File Chemical Structure Searching," to learn more about this important topic.

In his article, Stewart illustrates that only by searching multiple pipelines and using chemical structure searching can researchers be truly assured of a comprehensive search, thereby protecting investments made in current research.

Call for Contributors

Participate in knowledge sharing with your colleagues interested in pharmaceutical-related topics. Share your story suggestions with us at support.dialog.com/enewsletters/contribute/.